KRAS-driven tumors also show broader metabolic and signaling changes (including dysregulated glucose/glutamine/fatty acid metabolism and activation of MAPK and HIF-1-related cascades) that support tumor growth and indirectly reinforce immune escape [29]. Here, KRAS is linked to neoplasm.